Adenosine is a widespread neuromodulator within the CNS and its extracellular level is increased during hypoxia or intense synaptic activity, modulating pre-and postsynaptic sites. We studied the neuromodulatory action of adenosine on glutamatergic currents in the hippocampus, showing that activation of multiple adenosine receptors (ARs) by basal adenosine impacts postsynaptic site. Specifically, the stimulation of both A 1 R and A 3 R reduces AMPA currents, while A 2A R has an opposite potentiating effect. The effect of ARs stimulation on glutamatergic currents in hippocampal cultures was investigated using pharmacological and genetic approaches. A 3 R inhibition by MRS1523 increased GluR1-Ser845 phosphorylation and potentiated AMPA current amplitude, increasing the apparent affinity for the agonist. A similar effect was observed blocking A 1 R with DPCPX or by genetic deletion of either A 3 R or A 1 R. Conversely, impairment of A 2A R reduced AMPA currents, and decreased agonist sensitivity. Consistently, in hippocampal slices, ARs activation by AR agonist NECA modulated glutamatergic current amplitude evoked by AMPA application or afferent fiber stimulation. Opposite effects of AR subtypes stimulation are likely associated to changes in GluR1 phosphorylation and represent a novel mechanism of physiological modulation of glutamatergic transmission by adenosine, likely acting in normal conditions in the brain, depending on the level of extracellular adenosine and the distribution of AR subtypes.
INTRODUCTION
Purinergic signaling is emerging as one important mechanism of integrating functional activity between neurons, glial and vascular cells in the brain, through the action of both ATP and adenosine signaling (Burnstock et al., 2011) . Adenosine is a cellular metabolite formed by the breakdown of adenine nucleotides and is physiologically present at nanomolar to micromolar concentrations inside and outside the cells (Fredholm, 2007) . It represents an endogenous modulator of brain functions, fine-tuning glial function (Boison, 2007) , blood flow (Kusano et al., 2010) , but also inhibitory and excitatory synaptic transmission (Ribeiro and Sebastião, 2010) ; moreover, in the nervous system, the level of extracellular adenosine rises following brain damage, which occurs after stroke, ischemia, and epileptic seizures (Ribeiro et al., 2003) .
Basal extracellular adenosine concentration depends on the activity of both membrane nucleoside transporters (Parkinson et al., 2011; Diógenes et al., 2014) , and extracellular ectonucleotidases (Zimmermann et al., 2012) . It has been reported that the synaptic concentration of adenosine, tightly controlled by astrocytes and neurons, is usually higher than the intracellular one, and tonically modulates synaptic activity acting on adenosine receptors (ARs) A 1 R and A 2A R to regulate pre or post synaptic functions . The best characterized effect of adenosine is the presynaptic modulation of glutamatergic transmission (Dunwiddie and Fredholm, 1984) : presynaptic activation of A 1 R reduces glutamate release (Sebastião et al., 1990) , while activation of A 2A R increases glutamatergic transmission (Sebastião and Ribeiro, 1992; Cunha et al., 1994; Lopes et al., 2002) .
It is also known that adenosine may modulate synaptic transmission also acting at the postsynaptic level (Haas and Greene, 1984; Sebastião and Ribeiro, 2014) , regulating the activity of neurotransmitter receptors. Specifically, A 1 R activation inhibits AMPA and NMDA induced currents in the hippocampus (de Mendonça et al., 1995; Piccinin et al., 2010; Dias et al., 2012) , while A 2A R stimulation increases the amplitude of AMPAevoked and miniature postsynaptic currents enhancing GluR1 phosphorylation at Ser845 (Dias et al., 2012) . By contrast, few studies have focused on the role of A 3 receptors (A 3 R) in synaptic modulation, although these receptors have been identified in neurons (Lopes et al., 2003; Rebola et al., 2005) , astrocytes and microglial cells (Boison et al., 2010) and have a potential impact in glutamatergic modulation and synaptic plasticity (Costenla et al., 2001; Maggi et al., 2009; Piccinin et al., 2010) , in addition to their involvement in pain modulation (Ford et al., 2015) and neuroprotection (Chen et al., 2006; Pugliese et al., 2007; Dennis et al., 2011; Rosito et al., 2012 Rosito et al., , 2014 .
In this study we demonstrate the ability of A 3 R to negatively modulate postsynaptic AMPA receptors through the reduction of GluR1 phosphorylation level. Moreover, this effect is synergistic with the A 1 R mediated reduction of AMPA currents, and counteracts the potentiating effect of A 2A R activation. Importantly, we show that adenosine modulation is tonically active. Hence, the concomitant activity of A 1 R, A 2A R, and A 3 R tightly tunes glutamatergic synapses, setting the properties of AMPA receptors functioning in basal conditions.
MATERIALS AND METHODS

Animals
Procedures using laboratory animals were in accordance with the Italian and European guidelines and were approved by the Italian Ministry of Health in accordance with the guidelines on the ethical use of animals from the European Community Council Directive of 22 September 2010 (2010/63/EU). All efforts were made to minimize the number of animals used and their suffering.
Primary Hippocampal Neuronal Cultures
Hippocampal neuronal cultures were prepared as reported in Di Angelantonio et al. (2014) , from newborn (P0-P1) C57BL/6 and KO mice of either sex (Charles River Laboratory). In brief, after careful dissection from diencephalic structures, the meninges were removed and the hippocampi were chopped and digested in 1.25 mg/ml trypsin for 20 min at 37 • C. Cells were mechanically dissociated and plated at a density of 105 in poly-L-lysine coated glass coverslip (12 mm diameter) in serum-free Neurobasal medium, supplemented with B27 plus 2 mM L-glutamine and 100 μg/ml gentamicin (neuronal culture medium). Then, cells were kept at 37 • C in 5% CO 2 for 10-13 days with medium replacement (1:1 ratio) three times per week. With this method we obtained cultures composed by 60-70% neurons, 30-35% astrocytes, and 4-5% microglia, as determined with β-tubulin III, glial fibrillary acidic protein (GFAP), and isolectin IB4 staining (Lauro et al., 2008) . The same procedure was followed to prepare rat hippocampal culture used for some immunoblot experiments.
140 KCl, 2 MgCl 2 , 10 HEPES, 2 MgATP, 0.5 EGTA; pH 7.3, with KOH. During experiments, cultured neurons were continuously superfused with normal extracellular solution (NES) containing (in mM): 140 NaCl, 2.5 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 HEPES-NaOH, and 10 glucose (pH 7.3), added with tetrodotoxin (0.2 μM), using a gravity driven perfusion system, consisting of independent tubes for standard and agonist-containing solutions, connected to a fast exchanger system used to delivery all agonists (RSC-100; Bio-Logic). To activate glutamate receptors in hippocampal neurons in acute slices, AMPA was delivered together with cyclothiazide (25 μM; Tocris Cookson) by pressure application (5-15 psi, 10-100 ms; Picospritzer II, General Valve, Fairfield, NJ, USA) from glass micropipettes positioned above the slice over the soma of the recorded neuron. All other agonists were applied to hippocampal slices by bath perfusion.
In all recordings, AMPA was delivered together with cyclothiazide, to avoid fast receptor desensitization (Fucile et al., 2006) that could mask adenosine mediated AMPA receptor modulation. Cyclothiazide was always delivered in co-application with the agonist. Agonist concentration-current curves were constructed applying to each cell two or more different concentrations of agonist (10 nM-100 μM) at 60-120 s intervals and normalizing the current response to the plateau value, tested in all cells. Averaged data were best-fitted using Origin 7 (OriginLabCorp., Northampton, MA, USA) to the Hill equation:
Where I norm is the normalized current response, EC 50 is the agonist concentration yielding half-maximal current response and nH is the Hill coefficient. Membrane currents, recorded with a patch-clamp amplifier (Axopatch 200B; Molecular Devices, Foster city, CA, USA), were filtered at 2 kHz, digitized (10 kHz), and acquired with Clampex 10 software (Molecular Devices). The stability of the patch was checked by repetitively monitoring the input and series resistance during the experiment, and recordings were discarded when any of these parameters changed by >10%.
All recordings were performed at 24-25 • C, and cells were patch clamped at −70 mV.
Cell Stimulation and Western Blot Analysis
Ten DIV hippocampal cultures were incubated in Locke's buffer (in mM): 154 NaCl, 5.6 KCl, 3.6 NaHCO 3 , 2.3 CaCl 2 , 1 MgCl 2 , 5.6 glucose, buffered with 5 HEPES (pH 7.4) for 2 h and stimulated for 30 min with MRS1523 (100 nM).
Cells were then washed with PBS, scraped and lysed (TrisHCl 50 mm pH 7.5, NaCl 150 mm, EGTA 1 mm, EDTA 1 mm, 1%, Triton X-100, 0.1% SDS, phosphatase and protease inhibitor mixture). Protein concentration was determined by BCA assay (Pierce), and the same amounts of proteins (30 μg) were separated on 10% SDS-PAGE and analyzed by Western immunoblot using with antibodies specific for phospho-GluR1 Ser845 (Upstate Biotechnology, Lake Placid, NY, USA), and actin (Sigma). Immunoreactivity was detected by chemiluminescence (Immun-Star WesternC Kit; Bio-Rad). Specific bands on chemiluminescence films were quantified by densitometry with Sigma Gel Software (Jandel Scientific, Erkrath, Germany).
Drugs
SCH5821 (stock solution 10 mM in DMSO), DPCPX (stock solution 5 mM in DMSO), 2-Cl-IBMECA (stock solution 10 mM in DMSO), Bicuculline methochloride (stock solution 100 mM), AMPA (stock solution 100 mM), cyclothiazide (stock solution 50 mM in DMSO) and Tetrodotoxin citrate (stock solution 1 mM) were purchased from Tocris Bioscience, Bristol, UK. MRS1523 (stock solution 100 mM in DMSO) and all other drugs used were purchased from Sigma-Aldrich, Milan, Italy. Where not indicated, all drugs were dissolved in water.
Drug Application
During electrophysiological measurements, neurons were continuously superfused with NES, using a gravity driven perfusion system, consisting of independent tubes for standard and agonist-containing solutions, connected to a fast exchanger system (RSC-100; Bio-Logic) positioned 50-100 μm from the cell. Antagonists were usually acutely applied through parallel tubes of the same perfusion system or were pre-incubated for 1 h (37 • C) and then continuously applied during the experiments.
Data Analysis
Data, analyzed offline, are presented as mean ± SEM; we used the QuantityOne (Biorad) program for the densitometric analysis of all immunoblots. Origin 7 (Origin software; Microcal Software, Northampton, MA) and Sigmaplot 11 (Jandel scientific) software were used for statistical analysis. Paired and unpaired t-test and one-way ANOVA were used for parametrical data, as indicated; Holm-Sidak test was used as post hoc test; Mann and Withney test for non-parametrical data.
RESULTS
Modulation of AMPA Receptors by Basal Adenosine
It is well known that adenosine is present in brain extracellular space, as well as in neural preparations, such as brain slices or neuronal cultures. When we removed basal adenosine in hippocampal cultures with adenosine deaminase (ADA; 1 U/ml; 10 min), we observed a slow increase in the amplitude of currents evoked by AMPA application (10 μM; plus cyclothiazide, CTZ, 25 μM; to 120 ± 4%, n = 5, p < 0.05; Figure 1A ). This result suggests that adenosine present in the extracellular medium tonically depresses glutamatergic transmission by modulating the amplitude of AMPA currents.
To unveil the involvement of AR subtypes in AMPA current modulation, cultures were treated with specific ARs antagonists, in order to establish the possible contribution of A 1 R, A 2A R, and A 3 R.
When control cultures were superfused with the A 3 R specific antagonist MRS1523 (100 nM, 8 min), we observed a significant increase in the amplitude of AMPA currents (to 123.1 ± 7.9%, n = 5; p < 0.05; Figure 1B) . A similar effect was obtained treating cultures with the A 1 R specific antagonist DPCPX (100 nM), causing current amplitude increase to 123.8 ± 13.5% (n = 10, p < 0.05; not shown). Interestingly, when both A 3 R and A 1 R were blocked the current increase was significantly higher, suggesting an additive effect of the two antagonist (n = 5, p < 0.05 vs. MRS1523 or DPCPX alone, one way ANOVA, Holm-Sidak, Figure 1B) .
Conversely, the application of the specific A 2A R antagonist SCH58261 (30 nM; 8 min) caused a decrease in current amplitude (to 80.8 ± 4.6%; n = 5, p < 0.05; Figure 1B ).
In addition, prolonged treatment of hippocampal cultures with specific ARs antagonists (30 min preincubation and during recordings) significantly affected the AMPA current response amplitude (10 μM plus CTZ, 25 μM; Table 1 ); the mean current amplitude was in fact significantly enhanced by MRS1523 or DPCPX treatment, while it was reduced by SCH58261 ( Table 1) .
These data indicate that in hippocampal cultures, ARs are tonically active due to the presence of adenosine in the extracellular medium, and that this has a modulatory effect on glutamatergic currents. The stimulation of A 3 R or A 1 R subtypes causes a tonic depression of AMPA receptors, while A 2A R activation potentiates them; under basal condition, the inhibitory tone prevails, suggesting a predominance of A 1 R, A 3 R-mediated AMPAR modulation.
AMPA Receptors Affinity is Modulated by the Selective Activation of ARs
To understand how ARs activation could affect the AMPA receptor function, we measured the AMPA concentrationcurrent response curve in hippocampal neurons, both in control conditions or interfering with basal ARs activation. In particular, to unveil the contribution of single AR subtypes to GluRs modulation, we selectively abolished specific ARs activity either pharmacologically or genetically, using hippocampal cultures derived from A 1 R, A 2A R od A 3 R KO mice. When WT cells were treated with MRS1523 (100 nM), to block A 3 R, we observed a leftward shift in the AMPA concentrationresponse curve (Figure 2A) , corresponding to an increase in the agonist apparent affinity (Figure 2A ; Table 1 , n = 11) with a EC 50 value significantly different from the one observed in control conditions ( Table 1 , n = 32, p < 0.01), suggesting that basal A 3 R activation reduces GluR sensitivity for the agonist. Consistently, we observed an increase in the agonist affinity in hippocampal cultures derived from A 3 R KO mice (n = 11; Figure 2A ; Table 1 , p < 0.01).
Analogously, both the pharmacological inhibition by DPCPX (10 nM; n = 12) and the genetic deletion of A 1 R (hippocampal cultures derived from A 1 R KO mice), caused an increase in AMPA potency (Table 1, n = 8; p < 0.05).
Conversely, when A 2A R was inhibited by SCH58261 or deleted in A 2A R KO cultures, the apparent affinity for AMPA was decreased (n = 9, p < 0.05 and n = 12, p < 0.01 respectively; Figure 2B ; Table 1 ).
Altogether, these data indicate that GluRs functional properties are finely tuned by activation of different AR subtypes by basal adenosine. The sensitivity of GluRs is modulated in opposite directions by activation of ARs and in particular, A 3 R or A 1 R decrease agonist affinity, while it is increased by A 2A R. To investigate the cellular and molecular determinants underlying the A 3 R mediated modulation of AMPA currents, we performed experiments using the specific A 3 R agonist 2-Cl-IBMECA. To remove basal activation of ARs, control hippocampal cultures were treated with ADA (1 U/ml, 1 h preapplication and during the experiment) and current amplitude was monitored during the application of the specific A 3 R agonist 2-Cl-IBMECA. Consistently with the above reported results with A 3 R antagonist, the application of 2-Cl-IBMECA (10 nM, 10 min) reduced the AMPA current amplitude (to 60 ± 11%, n = 12, p < 0.01; Figure 3A) .
As expected, in cultures prepared from A 3 R KO mice, 2-Cl-IBMECA failed to reduce AMPA current (103 ± 3%; n = 13; p = 0.67; Figure 3A) , confirming that the observed effect was ascribable to specific A 3 R stimulation. To evaluate the possible contribution of glial A 3 R in the AMPA current modulation, we explored if glial A 3 R stimulation could rescue AMPA current modulation. To this purpose, A 3 R KO hippocampal cultures were seeded on a feeding layer of either A 3 R KO or WT glial cells: 2-Cl-IBMECA was ineffective both in A 3 R KO cultures seeded on WT glia (n = 14, p = 0.84; Figures 3A,B) and co-cultured with A 3 R KO glia (n = 12, p = 0.91), strongly indicating that 2-Cl-IBMECA acts specifically on neuronal A 3 R to modulate AMPA function.
Since A 3 R stimulation reduces cAMP accumulation (Zhou et al., 1992) , and PKA is responsible for GluR1 phosphorylation at Ser845 (Banke et al., 2000) , we studied the contribution of A 3 R in AMPAR phosphorylation to understand the intracellular pathway leading to the AMPA current modulation. To address this issue, ATP was substituted in the intracellular solution by ATPγS, in order to promote irreversible substrate thiophosphorylation (Eckstein, 1985) and thus to prevent the AMPAR dephosphorylation. As reported in Figure 4A , in this experimental condition 2-Cl-IBMECA (10 nM, ADA 1U/ml, n = 6, p < 0.05) failed to reduce the AMPA current amplitude. Consistently, MRS1523 (100 nM) application failed to potentiate AMPA-mediated currents when neuronal PKA was inhibited by intracellular perfusion with KT5720 ( Figure 4B ; n = 6; p = 0.83).
To test whether A 3 R modulation of AMPA currents could be associated to changes in GluR1 phosphorylation level, we exposed hippocampal cultures to MRS1523 (100 nM, 30 min) and evaluated the level of GluR1 phosphorylation at Ser845. Quantitative western blot analysis showed that, in MRS1523 treated cultures, the Ser845 phosphorylation increased to 125.6 ± 11.8% (n = 13, p < 0.03; Figure 4C ), indicating that tonic A 3 R activity reduces GluR1 phosphorylation. Altogether, these results indicate that the A 3 R activation modulates GluR functions through receptor dephosphorylation.
Modulation of Postsynaptic AMPA Receptors in Acute Hippocampal Slices by A 1 R, A 2A R and A 3 R Activation
To disclose the postsynaptic modulation of glutamatergic currents by ARs activation in hippocampal slices, we recorded the effect of the high affinity AR agonist N-ethyl 1-5 carboxamido adenosine (NECA) application on currents evoked by repetitive pressure application of AMPA (100 μM, plus CTZ 25μM) on CA1 pyramidal neurons. Prolonged NECA application (100 nM; 25 min) caused a reduction in the AMPA current amplitude (to 86.9 ± 2.2%, p < 0.01 paired t-test; n = 6; Figure 5A ), which did not recover within 20 min after drug washout ( Figure 5A) . We used combinations of specific ARs antagonist to disclose the contribution of single receptor subtypes ( Figure 5B ). In the presence of DPCPX (100 nM) plus SCH58261 (30 nM), allowing only the activation of A 3 R, NECA caused a reduction of the AMPA current amplitude (to 78.6 ± 4.5%; n = 5; p < 0.01, paired t-test), followed by a slow recovery after drug withdrawal. Smaller depression (to 90.0 ± 3.6%; n = 6, p < 0.05, paired t-test) was observed when NECA was applied in the presence of SCH58261 plus MRS1523 (100 nM), allowing only the activation of A 1 R (p < 0.05 respect to NECA in the presence of DPCPX plus SCH58261; One way ANOVA, Holm-Sidak, Figure 5C ). Conversely, in the presence of DPCPX plus MRS1523, NECA caused AMPA current potentiation, due to A 2A R stimulation (to 108.5 ± 5.1%, n = 6, p < 0.05, paired t-test). All together, these results indicate that also in hippocampal slices, activation of A 1 R, A 2A R and A 3 R modulates AMPA receptors.
To verify whether ARs modulation of AMPA receptors might affect glutamatergic synaptic transmission, we recorded, in CA1 pyramidal neurons, the excitatory postsynaptic currents (EPSCs) evoked by Schaffer collaterals stimulation. In this condition, we observed that basal adenosine, present in the slice preparation, modulates glutamatergic synaptic currents being EPSC amplitude increased by acute ADA application (Supplementary Figure S1A) . Moreover, as revealed using A 1 RKO and A 3 RKO mice, the application of high dose of adenosine induced an EPSC depression depending on both A 1 R and A 3 R (Supplementary Figures S1B,C) . In addition, NECA application caused a reduction of EPSCs amplitude (n = 7; p < 0.05; Figure 6A ), without affecting the paired pulse ratio (not shown), supporting a postsynaptic action of NECA that largely depends on the A 3 R activation. Indeed, NECA-mediated EPSCs depression was significantly smaller when A 3 R was blocked (MRS1523 100 nM, n = 4, p < 0.05 respect to NECA alone, one way ANOVA, Holm-Sidak; Figure 6B ), and it was abolished when A 1 R and A 2A R blockers (DPCPX 100 nM, SCH58261 30 nM) were simultaneously added (n = 7, p < 0.01 respect to NECA alone, one way ANOVA, Holm-Sidak; Figure 6B ).
These data confirm that the A 3 R activation may modulate glutamatergic synaptic transmission by a postsynaptic mechanism affecting AMPA receptor functions.
DISCUSSION
We report here that adenosine present in the extracellular milieu may tonically regulate the function of AMPA receptors acting on A 1 R, A 2A R, and A 3 R. Our data show that adenosine exerts multiple effects on glutamatergic transmission, modulating in opposite direction the apparent affinity of AMPA receptors, depending on AR subtypes. Our study is particularly focused on the effects of A 3 R stimulation, highlighting the role of this AR subtype in the modulation of glutamatergic transmission.
We propose that the A 3 R modulation of AMPA receptors is based on the alteration of the phosphorylation balance, at GluR1-Ser845, leading to changes in the apparent agonist affinity of the receptor. It is well known that phosphorylation affects the properties of the glutamate receptors (Banke et al., 2000) shifting the sensitivity to the transmitter/agonist (Lax et al., 2002) ; similar mechanisms could be involved in adenosinebased forms of synaptic modulation and plasticity (Ragozzino et al., 2006; Lauro et al., 2008; Piccinin et al., 2010; Scianni et al., 2013) . Our data show that the A 3 R stimulation causes a depression of the AMPA currents, which is likely associated with receptor dephosphorylation, since it is absent in the presence of ATPγS which promotes irreversible thio-phosphorylation of substrates (Eckstein, 1985) . Consistently, the treatment with the specific A 3 R blocker MRS1523 (i) causes the increase in the AMPA current amplitude, as confirmed in experiments on A 3 R KO cultures; (ii) is associated to the increase in the level of GluR1-Ser845 phosphorylation and (iii) is blocked by the PKA FIGURE 4 | A 3 R dependent AMPARs modulation requires GluR1 dephosphorylation. (A) Time course of the effect of the A 3 R agonist 2-Cl-IBMECA on AMPA current amplitude in the continuous presence of ADA (1 U/ml, 1 h preincubation) in control condition (black, n = 12) and after substitution of intracellular ATP with the thiophosphorylating agent ATPγS (n = 6). (B) Bar chart and sample traces displaying mean AMPA current potentiation induced by A 3 R antagonist MRS1523 in control and in the presence of PKA blocker KT5720 (n = 6). (C) Representative immunoblot and quantitative western blot analysis of the effect of MRS1523 on the level of basal Glur1 Ser845 phosphorylation (n = 13). * p < 0.05, * * p < 0.01.
antagonist KT5720. Indeed, adenosine is known to act through intracellular pathways involving PKA (Fredholm et al., 2001a) , potentially interfering with the phosphorylation of GluRs. In line with this, it has been shown that A 2A Rs stimulation leads to the potentiation of glutamatergic currents in hippocampal neurons and to GluR1 phosphorylation (Dias et al., 2012) . It has to be considered that both A 1 R and A 3 R are coupled to Gi/Go proteins, and that their activation leads to a decrease in the level of cAMP (Palmer et al., 1995; Lorenzen et al., 1998) . It can be thus hypothesized that the concomitant block of A 1 R and A 3 R will consistently increase the level of cAMP, possibly leading to a bigger effect respect to the one observed with a single receptor antagonist.
The effect of ARs stimulation on the amplitude of AMPAevoked currents is observed both in hippocampal cultures and in acute slices. It can be speculated that the modulation of agonist affinity may have relevance only on extrasynaptic GluRs, physiologically activated by low concentration of glutamate, as it is has been shown for adenosine modulation of GABA receptors (Rombo et al., 2014) . Indeed, our results show that the ARs stimulation by NECA, in particular A 3 R activation, also affects glutamatergic synaptic transmission in hippocampal slices, where GluRs are activated by high transmitter concentration (Clements, 1996) , depressing EPSCs amplitude. Moreover, EPSCs depression is not associated to a change in the paired pulse ratio, indicating a postsynaptic mechanism (Dobrunz and Stevens, 1997) .
It should be noted that EPSCs depression induced by NECA shows a peculiar pharmacology, likely reflecting a preferential action of the agonist on postsynaptic A 3 R, due to the higher NECA affinity for A 3 R compared to other ARs (Müller, 2003; Müller and Jacobson, 2011; Dal Ben et al., 2014) . Indeed, in our experimental conditions, extracellular adenosine might activate or desensitize presynaptic A 1 R. Thus, in addition to the well known A 1 R presynaptic modulation (Sebastião et al., 1990; Ribeiro, 2000, 2009; Boison, 2007) , the ARs stimulation may depress EPSCs by an A 3 R-dependent postsynaptic mechanism. The involvement of A 3 R in the glutamatergic synaptic modulation has been previously reported (Brand et al., 2001; Costenla et al., 2001; Piccinin et al., 2010) , particularly in hypoxic conditions (Hentschel et al., 2003; Pugliese et al., 2007) , when the adenosine extracellular level is highly increased (Fredholm, 2007) .
While interpreting the pharmacological results, it should be considered that basal adenosine may affect ARs to different extent; due to their desensitization properties (Klaasse et al., 2008) and that phenomena of re-sensitization may occur (Kompa and Summers, 1999) . In this respect, we consider convincing the consistency of data obtained with pharmacological and knock out approaches.
Results from this study clearly point to a role of basal adenosine in glutamatergic modulation; our data from hippocampal cultures show that removing different ARs, either by pharmacological or genetic approaches, causes changes in the functional properties of AMPA receptors (current amplitude and affinity for the agonist), pointing to tonic receptor modulation by ambient adenosine. Indeed, the AMPA current reduction induced by 2-Cl-IB-MECA was more pronounced in the presence of ADA (see Piccinin et al., 2010) , suggesting that basal adenosine might occlude the effect of exogenous agonist application.
It could be speculated that ADA might modulate per se AMPA receptor activity, however, although it has been hypothesized the ability of ADA to act independently from its enzymatic activity (Franco et al., 1997; Yamashita et al., 2012) , no data have been reported concerning the effect of extracellular ADA on the modulation of neurotransmitter receptors.
It should be noted that purines are released by brain cells through different mechanisms (Latini and Pedata, 2001 ) and that adenosine concentration may rise to the nanomolar range in hippocampal slices (Dale et al., 2000) . It can be speculated that this situation does not reflect the physiological status, representing one of the effects connected to slice or culture unnatural conditions (zur Nedden et al., 2011) . On the other hand, high adenosine level may be present in restricted sites (B,C) Time course and bar chart (at t = 25 min) of the effect of NECA in the presence of combination of ARs antagonists: DPCPX (100 nM) plus MRS1523 (100 nM) (gray; n = 6; p < 0.01); SCH58261 (30 nM) plus MRS1523 (dark green; n = 6; p < 0.05); DPCPX plus SCH58261 (green; n = 5; p < 0.01). * p < 0.05, * * p < 0.01, # p < 0.05, ## p < 0.01.
FIGURE 6 | Modulation of EPSC amplitude by NECA depends on A 3 R. (A) Left, time course of EPSC depression induced by adenosine receptor agonist NECA (100 nM) in hippocampal CA1 neurons in from acute slices in control conditions (black; n = 7; p < 0.05 at t = 25 min), in the presence of A 3 R antagonist MRS1523 (100 nM) (purple; n = 7; p < 0.05 respect to control and NECA alone) and in the presence of DPCPX + SCH58261 + MRS1523 (gray, n = 7). Right, sample EPCSs recorded in a CA1 pyramidal neuron in control and following NECA application. (B) Bar chart showing the effect of NECA (100 nM) alone (black), in the presence of the A 3 R antagonist (MRS1523 100 nM, purple) and in the presence of all three blockers (DPCPX + SCH58261+MRS1523 gray, n = 7). * p < 0.05, * * p < 0.01, # p < 0.05.
Frontiers in Cellular Neuroscience | www.frontiersin.orgduring high level of activity or in pathological conditions (Ribeiro et al., 2003; Wall and Dale, 2007) .
Our results show that adenosine may influence the glutamatergic neurotransmission through several independent mechanisms; in particular we show that the modulation of AMPA receptor by A 1 R (Lauro et al., 2008 ) is synergic with that of A 3 R, counteracting A 2A R-dependent AMPA receptor potentiation (see also Dias et al., 2012) . A 1 R, A 2A R and A 3 R are widely expressed at hippocampal synapses, both pre-and postsynaptically (Lopes et al., 2003; Rebola et al., 2005) . ARs are also expressed on glial cells (Burnstock et al., 2011) , however, in our conditions, the exclusive expression of A 3 R on glial cells was not sufficient to rescue the AMPA receptor modulation in A 3 R KO cultures, highlighting the role of neuronal A 3 R in A 3 R-dependent modulation.
It should be emphasized that the relevance and even the sign of adenosine modulation of synaptic transmission and plasticity (Scianni et al., 2013 ) will strongly depend on the level of expression and the regional distribution of different AR subtypes (Dixon et al., 1996; Fredholm and Svenningsson, 2003; Fukumitsu et al., 2005; Haeusler et al., 2015) . We speculate that this pathway of synaptic modulation could be suitable for the independent tuning of single synapses (West and Grace, 2002) . In addition, it has been proposed that due to time and space constraints, the source of adenosine may determine the AR subtype to be activated: adenosine originating from ATP released by astrocytes seems to target excitatory A 2A R (Cunha et al., 1994) , while released adenosine seems to prefer A 1 R (Lovatt et al., 2012) .
Since A 3 R is known to have lower affinity for adenosine (Müller and Jacobson, 2011, but see Fredholm et al., 2001b) compared to A 1 R and A 2A R, its activity may be relevant especially after acute brain insults, such as in ischemia and traumatic brain injury, when the extracellular level of adenosine dramatically increases (Fredholm, 2007) . In particular, the A 3 R activation can contribute to reduce over-excitability in order to counteract brain damage.
CONCLUSION
We show that adenosine, an ubiquitous brain mediator, may tune synaptic transmission through multiple mechanisms depending on the AR subtype expression. Such mechanisms of regulation are potentially highly relevant in the fine regulation of single synapses in relation to the level of synaptic activity or other conditions leading to the local increase of adenosine concentration.
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